FDA Drug recall D-214-2013
Levothyroxine Tablets, USP (levothyroxine sodium), 0.175 mg, 30 count bottles, Rx, Repacked & distributed by: Physicians Total Care, Inc.,…
- FDA Drug
- Class II
- terminated
- Published 2013-03-27
On 2013-03-27 the FDA classified a Class II recall of Levothyroxine Tablets, USP (levothyroxine sodium), 0.175 mg, 30 count bottles, Rx, Repacked & distributed by: Physicians Total Care, Inc.,… by Physicians Total Care, citing subpotent; 15 month stability (by mfr).
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-214-2013 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2012-11-15 |
| Published | 2013-03-27 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Physicians Total Care |
| Distribution | GA, OH |
Product
Levothyroxine Tablets, USP (levothyroxine sodium), 0.175 mg, 30 count bottles, Rx, Repacked & distributed by: Physicians Total Care, Inc., Tulsa, OK --- NDC 54868-4507-00
Reason
Subpotent; 15 month stability (by mfr)
Identifiers
| code_info | 6WX2 exp 12/31/2012 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-214-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.